Analysis Article • Jul 14
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 16, 2026
DataAggregated Company Financials
Companies7
- 7D-1.4%
- 3M-7.9%
- 1Y-23.0%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 3.0%, driven by a pullback from Oxford Nanopore Technologies of 0.8%. On the other hand Physiomics is actually up 16%. The industry has fallen 21% in the last year. As for the next few years, earnings are expected to grow by 54% per annum.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 16 Jul 2026 | UK£1.3b | UK£323.1m | -UK£164,731,254.00 | 1182.8x | -7.9x | 4x |
| Sat, 13 Jun 2026 | UK£1.3b | UK£323.0m | -UK£166,018,254.00 | 1243.9x | -8.1x | 4.1x |
| Mon, 11 May 2026 | UK£1.3b | UK£318.2m | -UK£167,469,254.00 | n/a | -8x | 4.2x |
| Wed, 08 Apr 2026 | UK£1.3b | UK£323.0m | -UK£156,192,254.00 | 8.9x | -8.5x | 4.1x |
| Fri, 06 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 10.8x | -8.8x | 4.4x |
| Sun, 01 Feb 2026 | UK£1.7b | UK£304.6m | -UK£159,441,254.00 | 7.7x | -10.9x | 5.7x |
| Tue, 30 Dec 2025 | UK£1.5b | UK£304.6m | -UK£159,441,254.00 | 8.1x | -9.1x | 4.8x |
| Thu, 27 Nov 2025 | UK£1.5b | UK£303.9m | -UK£162,910,254.00 | 7.5x | -9.5x | 5.1x |
| Sat, 25 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 8.9x | -9.8x | 5.3x |
| Mon, 22 Sep 2025 | UK£1.8b | UK£313.5m | -UK£158,190,352.00 | 6.3x | -11.1x | 5.6x |
| Wed, 20 Aug 2025 | UK£2.2b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -14x | 7.7x |
| Fri, 18 Jul 2025 | UK£1.6b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -10.2x | 5.6x |
| Sun, 15 Jun 2025 | UK£1.6b | UK£319.4m | -UK£190,737,820.90 | 7x | -8.1x | 4.9x |
| Tue, 13 May 2025 | UK£1.7b | UK£313.5m | -UK£193,250,439.80 | 11x | -9x | 5.5x |
| Thu, 10 Apr 2025 | UK£1.4b | UK£316.0m | -UK£186,811,949.20 | 5.7x | -7.6x | 4.5x |
| Sat, 08 Mar 2025 | UK£1.5b | UK£321.1m | -UK£182,126,379.44 | 6.7x | -8.4x | 4.8x |
| Mon, 03 Feb 2025 | UK£2.1b | UK£307.1m | -UK£195,661,147.68 | 7.5x | -10.6x | 6.7x |
| Wed, 01 Jan 2025 | UK£1.9b | UK£306.7m | -UK£195,343,454.64 | 8x | -9.5x | 6x |
| Fri, 29 Nov 2024 | UK£2.0b | UK£306.3m | -UK£192,798,395.12 | 8.4x | -10.2x | 6.4x |
| Sun, 27 Oct 2024 | UK£2.0b | UK£304.7m | -UK£192,569,494.30 | 10.8x | -10.4x | 6.6x |
| Tue, 24 Sep 2024 | UK£2.2b | UK£303.8m | -UK£191,679,415.50 | 11.5x | -11.5x | 7.3x |
| Thu, 22 Aug 2024 | UK£1.8b | UK£295.9m | -UK£188,464,296.90 | 12.5x | -9.7x | 6.2x |
| Sat, 20 Jul 2024 | UK£1.7b | UK£295.3m | -UK£189,720,861.18 | 12.9x | -9.1x | 5.9x |
| Mon, 17 Jun 2024 | UK£1.6b | UK£295.8m | -UK£189,931,418.67 | 11.6x | -8.2x | 5.3x |
| Wed, 15 May 2024 | UK£1.6b | UK£294.9m | -UK£187,719,596.75 | 7219.4x | -8.8x | 5.6x |
| Fri, 12 Apr 2024 | UK£1.6b | UK£317.5m | -UK£178,304,928.83 | 12.5x | -9.1x | 5.1x |
| Sun, 10 Mar 2024 | UK£1.9b | UK£292.8m | -UK£212,325,303.08 | 7210.6x | -9x | 6.5x |
| Tue, 06 Feb 2024 | UK£2.1b | UK£286.1m | -UK£189,521,420.51 | 6862.3x | -11.2x | 7.4x |
| Thu, 04 Jan 2024 | UK£3.1b | UK£450.1m | -UK£174,171,467.00 | 62x | -17.8x | 6.9x |
| Sat, 02 Dec 2023 | UK£3.1b | UK£455.2m | -UK£168,866,409.00 | 50.7x | -18.2x | 6.7x |
| Mon, 30 Oct 2023 | UK£3.0b | UK£458.8m | -UK£165,732,145.00 | 46.7x | -18x | 6.5x |
| Wed, 27 Sep 2023 | UK£3.0b | UK£448.1m | -UK£167,589,158.00 | 67.5x | -17.9x | 6.7x |
| Fri, 25 Aug 2023 | UK£3.1b | UK£476.4m | -UK£126,694,329.00 | 70.6x | -24.5x | 6.5x |
| Sun, 23 Jul 2023 | UK£3.5b | UK£476.2m | -UK£124,493,188.00 | 69.6x | -27.8x | 7.3x |
Price to Earnings Ratio
-27.8x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.2x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 0.70% | |
| Healthcare | -7.95% | |
| Life Sciences | -1.36% | |
| Clinical Research and Equipment | -1.36% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PYC Physiomics | UK£0.0055 | 15.8% +UK£339.9k | 15.8% | PS2.5x | |
| PRM Proteome Sciences | UK£0.02 | 1.5% +UK£105.2k | -34.2% | PS1.9x |
